Tianjin Medical University General Hospital

This study tests whether eculizumab can help people having a sudden attack of NMOSD, a rare autoimmune disease that damages the nerves in the eyes and spine. The drug works by blocking part of the immune system to stop nerve injury. About 110 adults who test positive for a specif…

This study tests whether the drug tocilizumab can safely prevent or delay relapses in people with MOGAD, a rare autoimmune disease that attacks the nervous system. About 102 participants aged 12 and older who have had at least one relapse in the past year will receive either toci…

This study aimed to see if eculizumab, a drug already approved to prevent attacks in neuromyelitis optica spectrum disorder (NMOSD), could also treat acute attacks. It was designed for adults with a specific antibody who had optic nerve or spinal cord inflammation for less than 1…